App-Quantinova.ai

Three-Year Clinical Outcome of Patients Treated With the Nobori Biolimus-Eluting Stent and Xience/Promus Cobalt-Chromium Everolimus-Eluting Stent for Unprotected Left Main Disease

Shoichi Kuramitsu - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Predictors Associated With 3-Year Adverse Clinical Outcomes Following Successful Left Main Intervention With Drug-Eluting Stents

Seung Woon Rha - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Impact of Total Stent Length After Sirolimus-Eluting Stent Implantation on 10-Year Clinical Outcomes

Shoichi Kuramitsu - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

Drug-Eluting Stents in the Treatment of Saphenous Vein Graft Disease: Disappointing Outcome During Long-term Follow-up

David L Fischman - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Nicardipine Hydrochloride

A Novel Wire guided Ablation Catheter For Ablation Of Right Superior Pulmonary Vein In Experimental Pigs

Hui Gong - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Oral Anticoagulation Therapy After Radiofrequency Ablation of Atrial Fibrillation and the Risk of Thromboembolism and Serious Bleeding: A Meta-analysis

Poonam Velagapudi - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Atrial Fibrillation is Associated With Higher Rates of Dementia in Patients Anticoagulated With Warfarin

Heidi T May - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Warfarin

Role of Systemic Ocreotide in Decreasing Recurrent Lower Gastrointestinal Bleeds Related to Arteriovenous Malformation in Patients on Systemic Oral Anticoagulation

Mojitaba Olayee - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

rivaroxaban

Coronary Microvascular Dysfunction in Patients With Acute Coronary Syndromes in the Absence of Obstructive Coronary Atherosclerosis

Giulio Russo - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

ergonovine

Rivaroxaban and Improved Modified Rankin Scale Score Among Patients With Acute Coronary Syndrome who Experience Stroke - Insights From the ATLAS ACS-2-TIMI-51 Clinical Trial

Serge Korjian - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

rivaroxaban

The Impact of Smoking on Clinical Outcomes and the Role of Double-Dose versus Standard-Dose Clopidogrel Among Individuals With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention - Insights From the CURRENT-OASIS 7 Trial

Darar Al Khdair - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Clopidogrel bisulfate

Inferior Vena Caval Filter Use for Prevention of Pulmonary Embolism: A Systematic Review

Saurav Chatterjee - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Distinguishing Clinical and Radiologic Features of Non-Traumatic Convexal Subarachnoid Hemorrhage

Jennifer Fugate - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Phase I Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Oral Protease-activated Receptor-4 Antagonist BMS-986120

Xuewen Ma - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

Tapered Stent Geometry Provides Strong Hemodynamic Effect After Carotid Stenting

Laura Cacioppa - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Gastrointestinal Bowel Obstruction in Acute Ischemic Stroke: Incidence, Risk Factors, and Outcomes

Adithi Y Reddy - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Risk of Acute Ischemic Stroke Increases During Severe Flares of Inflammatory Bowel Disease

Alexander E. Merkler - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Ability of the Khorana Score to Predict Recurrent Thromboembolism in Cancer Patients With Ischemic Stroke

Mary Cushman - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Appraising the Quality of Patient Care in Hospitalization for Transient Ischemic Attack

Adithi Y Reddy - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Substantial Progress yet Significant Opportunity for Improvement in Stroke Care in China

Yilong Wang - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Filters

7277 Abstracts